Literature DB >> 18183440

Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis.

J Corredoira1, M P Alonso, A Coira, E Casariego, C Arias, D Alonso, J Pita, A Rodriguez, M J López, J Varela.   

Abstract

The purpose of this study was to evaluate the characteristics of infective endocarditis (IE) caused by S. bovis and compare them to those caused by streptococci of the viridans group (SVG). A prospective study was undertaken considering 55 consecutive cases of IE due to S. bovis and 41 to SVG over 18 years. The study was divided into two periods (1988-1996 and 1997-2005). S. bovis caused 24% of the IE in our centre and constituted the main aetiology for this disease, showing an increase of 358% during the second period studied. Biotype I was responsible for 94.5% of cases and there was a high degree of association with colon tumours (53%). Over the period of the study, 107 patients admitted to our hospital had bacteraemia caused by S. bovis and 310 patients had bacteraemia caused by SVG. In the first group, 55 (51%) were endocarditis cases, but only 41 (13%) of the patients with SVG bacteraemia had endocarditis (p < 0.0001). The distinguishing features of endocarditis caused by S. bovis in comparison with those caused by SGV were: a greater increase in cases during the 2nd period studied (from 12 to 43 vs. from 19 to 22, p < 0.01), a higher percentage of males (93% vs. 71%, p < 0.004), patients significantly older (median age 66 vs. 58.5, p < 0.004), less predisposing cardiopathy (42% vs. 76%, p < 0.0009), more bivalvular involvement (42% vs. 22%, p < 0.04), more spondylitis (9% vs. 0%, p < 0.04), a higher association with colonic tumours (53% vs. 5%, p < 0.0001), and a higher percentage of antibiotic resistance: erythromycin 66% vs. 19%, p < 0.0001; clindamycin 67% vs. 11%, p < 0.0001; cotrimoxazole 77% vs. 30.5%, p < 0.0001, respectively. IE due to S. bovis is an emergent disease in our environment, presenting different characteristics to those produced by SVG.

Entities:  

Mesh:

Year:  2008        PMID: 18183440     DOI: 10.1007/s10096-007-0441-y

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  46 in total

1.  Tumors of the colon increase the risk of developing Streptococcus bovis endocarditis: case-control study.

Authors:  B Hoen; S Briançon; F Delahaye; V Terhé; J Etienne; M A Bigard; P Canton
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

2.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

3.  Geographical difference of disease association in Streptococcus bovis bacteraemia.

Authors:  Rodney A Lee; Patrick C Y Woo; Amanda P C To; Susanna K P Lau; Samson S Y Wong; Kwok-Yung Yuen
Journal:  J Med Microbiol       Date:  2003-10       Impact factor: 2.472

Review 4.  Epidemiologic aspects of infective endocarditis in an urban population. A 5-year prospective study.

Authors:  H Hogevik; L Olaison; R Andersson; J Lindberg; K Alestig
Journal:  Medicine (Baltimore)       Date:  1995-11       Impact factor: 1.889

5.  Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors:  R R Facklam
Journal:  Appl Microbiol       Date:  1972-06

6.  Streptococci and aerococci associated with systemic infection in man.

Authors:  M T Parker; L C Ball
Journal:  J Med Microbiol       Date:  1976-08       Impact factor: 2.472

7.  Clinical and morphological characteristics in Streptococcus bovis endocarditis: a comparison with other causative microorganisms in 177 cases.

Authors:  I Kupferwasser; H Darius; A M Müller; S Mohr-Kahaly; T Westermeier; H Oelert; R Erbel; J Meyer
Journal:  Heart       Date:  1998-09       Impact factor: 5.994

8.  Changing profile of infective endocarditis: results of a 1-year survey in France.

Authors:  Bruno Hoen; François Alla; Christine Selton-Suty; Isabelle Béguinot; Anne Bouvet; Serge Briançon; Jean-Paul Casalta; Nicolas Danchin; François Delahaye; Jerome Etienne; Vincent Le Moing; Catherine Leport; Jean-Luc Mainardi; Raymond Ruimy; François Vandenesch
Journal:  JAMA       Date:  2002-07-03       Impact factor: 56.272

9.  Long-term complications of native valve infective endocarditis in non-addicts. A 15-year follow-up study.

Authors:  M P Tornos; G Permanyer-Miralda; M Olona; M Gil; E Galve; B Almirante; J Soler-Soler
Journal:  Ann Intern Med       Date:  1992-10-01       Impact factor: 25.391

Review 10.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more
  28 in total

1.  Reidentification of Streptococcus bovis isolates causing bacteremia according to the new taxonomy criteria: still an issue?

Authors:  Beatriz Romero; María-Isabel Morosini; Elena Loza; Mercedes Rodríguez-Baños; Enrique Navas; Rafael Cantón; Rosa Del Campo
Journal:  J Clin Microbiol       Date:  2011-07-13       Impact factor: 5.948

2.  Association between Streptococcus bovis and colon cancer.

Authors:  Annemarie Boleij; Renée M J Schaeps; Harold Tjalsma
Journal:  J Clin Microbiol       Date:  2009-02       Impact factor: 5.948

3.  Selective antibody response to Streptococcus gallolyticus pilus proteins in colorectal cancer patients.

Authors:  Annemarie Boleij; Rian Roelofs; Camille Danne; Samuel Bellais; Shaynoor Dramsi; Ikuko Kato; Harold Tjalsma
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-19

4.  Characterization of high-level daptomycin resistance in Viridans group Streptococci developed upon in vitro exposure to daptomycin.

Authors:  Ronda L Akins; Bradley D Katz; Catherine Monahan; Dylan Alexander
Journal:  Antimicrob Agents Chemother       Date:  2015-01-26       Impact factor: 5.191

5.  Streptococcus bovis new taxonomy: does subspecies distinction matter?

Authors:  E Ben-Chetrit; Y Wiener-Well; L Kashat; A M Yinnon; M V Assous
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-10-28       Impact factor: 3.267

6.  Infective endocarditis caused by Streptococcus gallolyticus subspecies pasteurianus and colon cancer.

Authors:  Noriko Takamura; Tsuneaki Kenzaka; Kensuke Minami; Masami Matsumura
Journal:  BMJ Case Rep       Date:  2014-05-05

7.  Streptococcus gallolyticus: a single bacteria, two different conditions.

Authors:  Cristiano Silva Cruz; Catarina Machado; André Almeida; Rita Barata Moura
Journal:  BMJ Case Rep       Date:  2015-07-01

8.  Increased exposure to bacterial antigen RpL7/L12 in early stage colorectal cancer patients.

Authors:  Annemarie Boleij; Rian Roelofs; Renée M J Schaeps; Tanja Schülin; Philippe Glaser; Dorine W Swinkels; Ikuko Kato; Harold Tjalsma
Journal:  Cancer       Date:  2010-09-01       Impact factor: 6.860

9.  The Pil3 pilus of Streptococcus gallolyticus binds to intestinal mucins and to fibrinogen.

Authors:  Mariana Martins; Constance Porrini; Laurence du Merle; Camille Danne; Catherine Robbe-Masselot; Patrick Trieu-Cuot; Shaynoor Dramsi
Journal:  Gut Microbes       Date:  2016-09-22

10.  Surface-exposed histone-like protein a modulates adherence of Streptococcus gallolyticus to colon adenocarcinoma cells.

Authors:  Annemarie Boleij; Renée M J Schaeps; Stan de Kleijn; Peter W Hermans; Philippe Glaser; Vijay Pancholi; Dorine W Swinkels; Harold Tjalsma
Journal:  Infect Immun       Date:  2009-09-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.